Exploring 5-IT. To explore a different substance…

Names:
5-API
5-IT
5-(2-Aminopropyl)indole
3,4-Pyrrolo[b]amphetamine
IUPAC name:
1-(1H-Indol-5-yl)propan-2-amine
5534 · C11H14N2 · 174.242
InChI=1S/C11H14N2/c1-8(12)6-9-2-3-11-10(7-9)4-5-13-11/h2-5,7-8,13H,6,12H2,1H3
AULGMISRJWGTBA-UHFFFAOYSA-N This stereoisomer Any stereoisomer
CC(Cc1ccc2c(c1)cc[nH]2)N

Elliott, SP; Brandt, SD; Freeman, S; Archer, RP. AMT (3-(2-aminopropyl)indole) and 5-IT (5-(2-aminopropyl)indole): an analytical challenge and implications for forensic analysis. Drug Test. Analysis, 1 Mar 2013, 5 (3), 196–202. 794 kB. https://doi.org/10.1002/dta.1420

Herraiz, T; Brandt, SD. 5-(2-Aminopropyl)indole (5-IT): a psychoactive substance used for recreational purposes is an inhibitor of human monoamine oxidase (MAO). Drug Test. Analysis, 1 Jul 2014, 6 (7-8), 607-613. 567 kB. https://doi.org/10.1002/dta.1530

EMCDDA. Report on the risk assessment of 5-(2-aminopropyl)indole (5-IT), European Monitoring Centre for Drugs and Drug Addiction, Jan 2014. 955 kB.

EMCDDA. New drugs in Europe, 2012, European Monitoring Centre for Drugs and Drug Addiction, 1 May 2013. 773 kB. #29

Luethi, D; Kolaczynska, KE; Docci, L; Krähenbühl, S; Hoener, MC; Liechti, ME. Pharmacological profile of mephedrone analogs and related new psychoactive substances. Neuropharmacology, 26 Jul 2017, n/a. 2.6 MB. https://doi.org/10.1016/j.neuropharm.2017.07.026 #5-IT

EMCDDA. New drugs in Europe, 2013, European Monitoring Centre for Drugs and Drug Addiction, 1 Jul 2014. 311 kB.

Wagmann, L; Brandt, SD; Kavanagh, PV; Maurer, HH; Meyer, MR. In vitro monoamine oxidase inhibition potential of alpha-methyltryptamine analog new psychoactive substances for assessing possible toxic risks. Toxicol. Lett., 17 Apr 2017, 272, 84–93. 1.9 MB. https://doi.org/10.1016/j.toxlet.2017.03.007

Kavanagh, PV; Power, JD. New psychoactive substances legislation in Ireland – Perspectives from academia. Drug Test. Analysis, 1 Jul 2014, 6 (7-8), 884-891. 1.2 MB. https://doi.org/10.1002/dta.1598

King, LA. New phenethylamines in Europe. Drug Test. Analysis, 1 Jul 2014, 6 (7-8), 808-818. 472 kB. https://doi.org/10.1002/dta.1570

Griffiths, P; Evans-Brown, M; Sedefov, R. Getting up to speed with the public health and regulatory challenges posed by new psychoactive substances in the information age: Editorial. Addiction, 1 Jan 2013, 108 (10), 1700-1703. 93 kB. https://doi.org/10.1111/add.12287

Shulgin, AT. Basic Pharmacology and Effects. In Hallucinogens. A Forensic Drug Handbook; Laing, R; Siegel, JA, Eds., Academic Press, London, 2003; pp 67–137. 6.3 MB.

Simmler, LD; Liechti, ME. Pharmacology of MDMA- and amphetamine-like new psychoactive substances. In Handbook of Experimental Pharmacology; , Springer Berlin Heidelberg, 1 Jan 2018; . 298 kB. https://doi.org/10.1007/164_2018_113

Taschwer, M; Ebner, E; Schmid, MG. Test purchase of new synthetic tryptamines via the Internet: Identity check by GC-MS and separation by HPLC. J. Appl. Pharm. Sci., 1 Jan 2016, 6 (1), 028–034. 504 kB. https://doi.org/10.7324/JAPS.2016.600105

Wagmann, L; Brandt, SD; Stratford, A; Maurer, HH; Meyer, MR. Interactions of phenethylamine-derived psychoactive substances of the 2C-series with human monoamine oxidases. Drug Test. Analysis, 6 Sep 2018, n/a. 650 kB. https://doi.org/10.1002/dta.2494 #5-IT

AMT · α-MT
NMT
α-Me-isoT
5-Me-T
7-Me-T
6-IT
7-IT
Homotryptamine
10201
10197
PEA-P · Desmethyl fenproporex
1-IT
22 October 2018 · Creative Commons BY-NC-SA ·